29 november 2018
On 27 November 2018 the Court of Appeal of The Hague in the Netherlands reversed the first instance court’s decision, confirming the validity of AstraZeneca’s patents on their breast cancer drug Faslodex® and reinstating the earlier injunction against Sandoz in PI proceedings. With this decision the Court of Appeal confirms…
Lees meer
29 september 2022
We are very proud of our confirmed Tier 1 position in JUVE Patent’s latest rankings for the Netherlands, listing Dutch patent practices, patent attorneys and litigators who, according to JUVE’s research, have a leading reputation in the Dutch patent law market. “The market-leading Dutch patent…
Lees meer